Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 5830103, 8 pages
http://dx.doi.org/10.1155/2016/5830103
Research Article

Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses

Department of Pathology, Microbiology, Immunology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA

Received 16 March 2016; Revised 9 June 2016; Accepted 19 June 2016

Academic Editor: Phuc Van Pham

Copyright © 2016 Sean D. Owens et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Kol, J. A. Wood, D. D. C. Holt et al., “Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses,” Stem Cell Research & Therapy, vol. 6, article 73, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. M. M. Lalu, L. McIntyre, C. Pugliese et al., “Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials,” PLoS ONE, vol. 7, no. 10, Article ID e47559, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Ankrum, J. F. Ong, and J. M. Karp, “Mesenchymal stem cells: immune evasive, not immune privileged,” Nature Biotechnology, vol. 32, no. 3, pp. 252–260, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Trounson and C. McDonald, “Stem cell therapies in clinical trials: progress and challenges,” Cell Stem Cell, vol. 17, no. 1, pp. 11–22, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Le Blanc, C. Tammik, K. Rosendahl, E. Zetterberg, and O. Ringdén, “HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells,” Experimental Hematology, vol. 31, no. 10, pp. 890–896, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Sundin, O. Ringdén, B. Sundberg, S. Nava, C. Götherström, and K. Le Blanc, “No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients,” Haematologica, vol. 92, no. 9, pp. 1208–1215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Hare, J. E. Fishman, G. Gerstenblith et al., “Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial,” Journal of the American Medical Association, vol. 308, no. 22, pp. 2369–2379, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. L. M. Pezzanite, L. A. Fortier, D. F. Antczak et al., “Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo,” Stem Cell Research and Therapy, vol. 6, no. 1, article 54, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Sun, K. Akiyama, H. Zhang et al., “Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans,” Stem Cells, vol. 27, no. 6, pp. 1421–1432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. I. A. Isakova, C. Lanclos, J. Bruhn et al., “Allo-reactivity of mesenchymal stem cells in Rhesus Macaques is dose and haplotype dependent and limits durable cell engraftment in vivo,” PLoS ONE, vol. 9, no. 1, Article ID e87238, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. C. A. Toupadakis, A. Wong, D. C. Genetos et al., “Comparison of the osteogenic potential of equine mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord blood, and umbilical cord tissue,” American Journal of Veterinary Research, vol. 71, no. 10, pp. 1237–1245, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Moll, I. Rasmusson-Duprez, L. von Bahr et al., “Are therapeutic human mesenchymal stromal cells compatible with human blood?” STEM CELLS, vol. 30, no. 7, pp. 1565–1574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. E. M. Schuh, M. S. Friedman, D. D. Carrade et al., “Identification of variables that optimize isolation and culture of multipotent mesenchymal stem cells from equine umbilical-cord blood,” American Journal of Veterinary Research, vol. 70, no. 12, pp. 1526–1535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. D. Owens, J. Snipes, K. G. Magdesian, and M. M. Christopher, “Evaluation of a rapid agglutination method for detection of equine red cell surface antigens (Ca and Aa) as part of pretransfusion testing,” Veterinary Clinical Pathology, vol. 37, no. 1, pp. 49–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. L. J. Gershwin, K. A. Netherwood, M. S. Norris, N. E. Behrens, and M. X. Shao, “Equine IgE responses to non-viral vaccine components,” Vaccine, vol. 30, no. 52, pp. 7615–7620, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. D. D. Carrade, S. D. Owens, L. D. Galuppo et al., “Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses,” Cytotherapy, vol. 13, no. 4, pp. 419–430, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. K. C. Clark, A. Kol, S. Shahbenderian, J. L. Granick, N. J. Walker, and D. L. Borjesson, “Canine and equine mesenchymal stem cells grown in serum free media have altered immunophenotype,” Stem Cell Reviews and Reports, vol. 12, no. 2, pp. 245–256, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Sole, M. Spriet, K. A. Padgett et al., “Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb,” Equine Veterinary Journal, vol. 45, no. 6, pp. 726–731, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Sole, M. Spriet, L. D. Galuppo et al., “Scintigraphic evaluation of intra-arterial and intravenous regional limb perfusion of allogeneic bone marrow-derived mesenchymal stem cells in the normal equine distal limb using 99mTc-HMPAO,” Equine Veterinary Journal, vol. 44, no. 5, pp. 594–599, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Bartholomew, C. Sturgeon, M. Siatskas et al., “Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo,” Experimental Hematology, vol. 30, no. 1, pp. 42–48, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Schu, M. Nosov, L. O'Flynn et al., “Immunogenicity of allogeneic mesenchymal stem cells,” Journal of Cellular and Molecular Medicine, vol. 16, no. 9, pp. 2094–2103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. K. J. Beggs, A. Lyubimov, J. N. Borneman et al., “Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons,” Cell Transplantation, vol. 15, no. 8-9, pp. 711–721, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Pappous and P. Verbelis, “Allergic reactions in cattle vaccinated against foot and mouth disease with vaccines based on viruses cultivated on BHK cells in roller bottles,” Developments in Biological Standardization, vol. 35, pp. 97–101, 1976. View at Google Scholar · View at Scopus
  24. P. Sizaret, P. Reculard, Y. Caraes, and B. Virat, “Etiology of some primary serum shocks. Iv. Demonstration and explanation of the presence of equine antigens in an anti-swine erysipelas a vaccine. Demonstration of these antigens in 2 other vaccines,” Annales de l'Institut Pasteur (Paris), vol. 160, pp. 95–107, 1964. View at Google Scholar
  25. K. Ohmori, K. Masuda, S. Maeda et al., “IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination,” Veterinary Immunology and Immunopathology, vol. 104, no. 3-4, pp. 249–256, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. E. M. Horwitz, P. L. Gordon, W. K. K. Koo et al., “Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 13, pp. 8932–8937, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. J. L. Spees, C. A. Gregory, H. Singh et al., “Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy,” Molecular Therapy, vol. 9, no. 5, pp. 747–756, 2004. View at Publisher · View at Google Scholar · View at Scopus